NYU Langone Health: Lupus Erythematosus, Systemic trials

The registry lists 12 Lupus Erythematosus, Systemic studies with NYU Langone Health as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 2Phase 3 3Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• HEALTH Home Urinalysis TestingRecruitingNCT07823478Not applicable
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseaseRecruitingNCT05799378Phase 3
• Safety of the Herpes Zoster Subunit Vaccine in LupusRecruitingNCT05559671Phase 4
• HEAL-SLE: Holistic Energy for Alleviating Lupus SymptomsActive, not recruitingNCT07203157Not applicable
• Acthar SLE (Systemic Lupus Erythematosus)WithdrawnNCT02779153Phase 4
• Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol BalanceCompletedNCT01180361
• Preventive IVIG Therapy for Congenital Heart BlockCompletedNCT00460928Early Phase 1
• The Research Registry for Neonatal LupusCompletedNCT00074373
• Serologically Active, Clinically Stable Systemic Lupus ErythematosusCompletedNCT00000421Phase 2
• Safety of Estrogens in Lupus: Birth Control PillsCompletedNCT00000420Phase 3
• Safety of Estrogens in Lupus: Hormone Replacement TherapyTerminatedNCT00000419Phase 3